BIBLIOGRAFIA

American Diabetes Association: Standards of medical care for patients with diabetes mellitus (Position Statement). Diabetes Care 24: (Suppl. 1):S33–S43, 2001

American Diabetes Association: Treatment of hypertension in diabetes (Consensus Statement). Diabetes Care 16:1394–1401, 1993

Bennett PH, Haffner S, Kasiske BL, Keane WF, Mogensen CE, Parving H-H, Steffes MW, Striker GE: Screening and management of microalbuminuria in patients with diabetes mellitus. Am J Kidney Dis 25:107–112, 1995

DeFronzo RA: Diabetic nephropathy: etiologic and therapeutic considerations. Diabetes Rev 3:510–564, 1995

Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986, 1993

Jacobson HR, Striker GE for the Workshop Group: Report on a workshop to develop management recommendations for the prevention of progression in chronic renal disease. Am J Kidney Dis 25:103–106, 1995

Krolewski AS, Warram JH: Natural history of diabetic nephropathy. Diabetes Rev 3:446– 459, 1995

Mogensen CE, Keane WF, Bennett PH, Jerums G, Parving H-H, Passa P, Steffes MW, Striker GE, Viberti GC: Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 346:1080–1084, 1995

Nielson FS, Rossing P, Gall MA, Skott P, Smidt UM, Parving HH: Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy. Diabetes 46:1182–1188, 1997

Ohkubo Y, Kishikawa H, Araki E: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28:103–117, 1995

Reichard P, Nilsson BY, Rosenqvist V: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329: 304–309, 1993

UK Prospective Diabetes Study Group: Efficacy of atenolol and captopril in reducing the risk of macrovascular complications in type 2 diabetes (UKPDS 39). BMJ 317:713–720, 1998

UK Prospective Diabetes Study Group: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853, 1998